Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center

Pediatric Pulmonology

Volumn 34, Issue 4, 2002, Pages 257-261

  Denton, M ^a,b,c   Kerr, K ^a,b   Mooney, L ^a,b   Keer, V ^a,b   Rajgopal, A ^a,b   Brownlee, K ^a,b   Arundel, P ^a,b   Conway, S ^a,b  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Colistin; Cystic fibrosis; Pseudomonas aeruginosa; Transmission

Indexed keywords

COLISTIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; GENOTYPE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; LUNG FUNCTION TEST; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COLISTIN; CROSS INFECTION; CYSTIC FIBROSIS; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TIME FACTORS;

EID: 0036785981     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10166     Document Type: Article

References (21)

1. Hoiby N. Pseudomonas infection in cystic fibrosis. In: Dodge JA, Brock DJ, Widdicombe JH, editors. Cystic fibrosis-current topics, volume 1. Chichester: Wiley; 1993. p 251-268.
2. Koch C, Hoiby N. Pathogenesis of cystic fibrosis. Lancet 1993; 341:1065-1069.
3. Fredericksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-335.
4. Conway SP. Evidence for using nebulised antibiotics in cystic fibrosis. Arch Dis Child 1999;80:307-309.
5. Denton M, Wilcox MH. Antimicrobial treatment of pulmonary colonization and infection by Pseudomonas aeruginosa in cystic fibrosis patients. J Antimicrob Chemother 1997;40:468-474.
6. Bums JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, Ramsey BW, Clausen CR. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998;27:158-163.
7. Conway SP, Pond MN, Watson A, Etherington C, Robey HL, Goldman MH. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax 1997;52:987-993.
8. Ledson MJ, Gallagher MJ, Cowperthwaite C, Convery RP, Walshaw MJ. Four years' experience of intravenous colomycin in an adult cystic fibrosis unit. Eur Respir J 1998;12:592-594.
9. Pedersen SS, Koch C, Hoiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother 1986;17:505-516.
10. Cheng K, Smyth RL, Govan JRW, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996;348:639-642.
11. Tummler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp G, von der Hardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients. J Clin Microbiol 1991;29: 1265-1267.
12. Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert D. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 1996;34:1129-1135.
13. da Silva Filho LV, Levi JE, Bento CN, Rodrigues JC, da Silvo Ramos SR. Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic. J Med Microbiol 2001;50:261-267.
14. Tubbs D, Lenney W, Alcock P, Campbell CA, Gray J, Pantin C. Pseudomonas aeruginosa in cystic fibrosis: cross-infection and the need for segregation. Respir Med 2001;95:147-152.
15. Grothues D, Koopmann U, von der Hardt H, Tummler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol 1988;26:1973-1977.
16. Ojeniyi B, Frederiksen B, Hoiby N. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000;29:177-181.
17. Moskowitz SM, Burns JL, Miller SI, Ernst RK, Hoiby N, Nguyen CD. Polymyxin resistance and lipid A structure of Pseudomonas aeruginosa isolated from colistin-treated and colistin-naive cystic fibrosis patients. Pediatr Pulmonol [Suppl] 2000;20:272.
18. British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother [Suppl] 1991;27:41-43.
19. Gautom RK. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other Gram negative organisms in 1 day. J Clin Microbiol 1997;35:2977-2980.
20. Bosshammer J, Fiedler B, Gudowius P, von der Hardt H, Romling U, Tummler B. Comparative hygienic surveillance of contamination with pseudomonads in a cystic fibrosis ward over a 4-year period. J Hosp Infect 1995;31:261-274.
21. Zembrzuska-Sadkowska E, Sneum M, Ojeniyi B, Heiden L, Hoiby N. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in the Danish Cystic Fibrosis Centre. J Hosp Infect 1995;29:1-7.